Reporting Late Rectal Toxicity in Prostate Cancer Patients Treated With Curative Radiation Treatment

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 3, 2008, Pages 777-781

  Faria, Sergio L ^a   Souhami, Luis ^a   Joshua, Bosede ^a   Vuong, Te ^a   Freeman, Carolyn R ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Late toxicity; Prostate cancer; Radiotherapy; Rectal toxicity

Indexed keywords

CHLORINE COMPOUNDS; ELECTROTHERAPEUTICS; PATIENT MONITORING; RADIOTHERAPY;

LATE TOXICITY; LOCALIZED PROSTATE CANCER; LONG-TERM OUTCOME; PROSTATE CANCER; RADIATION TREATMENTS; RADIOTHERAPY ALONE; RECTAL TOXICITY; SIDE EFFECTS;

TOXICITY;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CONTROLLED STUDY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RECTUM DISEASE; UROGENITAL TRACT DISEASE;

AGED; DOSE FRACTIONATION; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; HUMANS; MALE; MALE UROGENITAL DISEASES; MIDDLE AGED; PHOTONS; PROSTATIC NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RECTAL DISEASES; TIME FACTORS;

EID: 52949124816     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.02.030     Document Type: Article

References (19)

1. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41 (1998) 491-500
2. Brenner D.J., and Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43 (1999) 1095-1101
3. Falco T., Shenouda G., Belanger I., et al. Ultrasound imaging for external-beam prostate treatment setup and dosimetric verification. Med Dosim 27 (2002) 271-273
4. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), US Department of Health and Human Services, National Institute of Health, 2003. Available at: http://www.fda.gov/cder/cancer/toxicityframe.htm. Accessed Sept 17, 2007.
5. Loblaw D.A., and Cheung P. External beam irradiation for localized prostate cancer: The promise of hypofractionation. Can J Urol 1 (2006) 62-66
6. Schultheiss T.E., Lee W.R., Hunt M.A., et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 37 (1997) 3-11
7. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the MD Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
8. Peeters S.T., Heemsbergen W.D., Putten W.L., et al. Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 61 (2005) 1019-1034
9. Kupelian P.A., Thakkar V.V., Khuntia D., et al. Hypofractionated intensity modulated (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long-term outcomes. Int J Radiat Oncol Biol Phys 63 (2005) 1463-1468
10. Skwarchuk M.W., Jackson A., Zelefsky M.J., et al. Late rectal toxicity after conformal radiotherapy of prostate cancer: Multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 47 (2000) 103-113
11. Dawson L.A., Mah K., Franssen E., et al. Target position variability throughout prostate radiotherapy. Int J Radiat Oncol Biol Phys 42 (1998) 1155-1161
12. Poli M.E., Parker W., Patrocinio H., et al. An assessment of PTV margin definitions for patients undergoing conformal 3D external beam radiation therapy for prostate cancer based on an analysis of 10,327 pretreatment daily ultrasound localizations. Int J Radiat Oncol Biol Phys 67 (2007) 1430-1437
13. Kupelian P.A., Reddy C.A., Klein E.A., et al. Short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy fraction) for localized prostate cancer. Int J Radiat Oncol Biol Phys 51 (2001) 988-993
14. Boehmer D., Kuczer D., Badakhshi H., et al. Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy. Strahlenther Onkol 182 (2006) 277-282
15. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 32 (1995) 567-576
16. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53 (2002) 1111-1116
17. Michlaski J.M., Winter K., Purdy J.A., et al. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose level V. Int J Radiat Oncol Biol Phys 62 (2005) 706-713
18. Ataman F., Zurlo A., Artigman X., et al. Late toxicity following conventional radiotherapy for prostate cancer: Analysis of the EORTC trial 22863. Eur J Cancer 40 (2004) 1674-1681
19. Ryu J.K., Winter K., Michalski J.M., et al. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2Gy). Int J Radiat Oncol Biol Phys 54 (2002) 1036-1046